REQUEST A DEMO
Total
USD $0.00
Search more companies

Orteks OOO (Reutov) (Ортэкс ООО (Реутов)) (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Orteks OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Orteks OOO (Reutov) (Ортэкс ООО (Реутов)) is based in Russia. The head office is in Reutov. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on May 05, 2006. The total number of employees is currently 2 (2022). From the latest financial highlights, Orteks OOO (Reutov) (Ортэкс ООО (Реутов)) reported a net sales revenue increase of 40.95% in 2024. Its total assets grew by 4.37% over the same period. The enterprise’s net profit margin increased by 6.35% in 2024.

Headquarters
Nekrasova, 12
Reutov; Moscow Oblast; Postal Code: 143968

Contact Details: Purchase the Orteks OOO (Reutov) (Ортэкс ООО (Реутов)) report to view the information.

Basic Information
Total Employees:
Purchase the Orteks OOO (Reutov) (Ортэкс ООО (Реутов)) report to view the information.
Registered Capital:
Purchase the Orteks OOO (Reutov) (Ортэкс ООО (Реутов)) report to view the information.
Financial Auditors:
Purchase the Orteks OOO (Reutov) (Ортэкс ООО (Реутов)) report to view the information.
Incorporation Date:
May 05, 2006
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Orteks OOO (Reutov) (Ортэкс ООО (Реутов)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
40.95%
Total operating revenue
40.95%
Operating profit (EBIT)
88.85%
Net Profit (Loss) for the Period
87.87%
Total Assets
4.37%
Total Equity
61.44%
Operating Profit Margin (ROS)
7.2%
Net Profit Margin
6.35%
Return on Equity (ROE)
5.36%
Quick Ratio
14.89%
Cash Ratio
4.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?